RxDoctor Payments Data

Benjamin Levi, MD

Surgery · Dallas, TXNPI 1932228871

Payments from drug & device makers

What this record shows

This record is dominated by education: $2,000 of the $2,131 with a category attached, or 93.8%. Ipsen Biopharmaceuticals, Inc accounts for 93.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $2,040 and has fallen 98.6% since, to $29 in 2023. That places this record below the midpoint for surgery clinicians in TX, where the typical reported total is $2,700.

$2,131in general payments, 2019–2025

Across 5 payments — averaging $426.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$2K
  • Sientra, Inc.$62
  • Avita Medical Americas, LLC$40
  • AbbVie$29
$143,000in research payments, 2019–2025

Across 1 payment — averaging $143,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$143K

What the payments were for

  • Food & beverage$1316%
  • Education$2,00094%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,131 in reported general payments places this provider in the 45th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas

Medicare billing

Part B allowed, 2024
$17,631
Medicare patients
15
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →